The Impact of Cetuximab Plus AKT- Or mTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model With Wild-Type RAS and PIK3CA Mutation
Journal of Cancer - Australia
doi 10.7150/jca.19458
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2017
Authors
Publisher
Ivyspring International Publisher